 SUZHOU and SHANGHAI, China, Jan. 19, 2021 PRNewswire -- Gracell Biotechnologies Inc. NASDAQ: GRCL Gracell, a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced that... 